The Advanced Therapies Congress is Europe’s largest and most significant commercial cell and gene therapy conference and exhibition. This premier event is essential for the leaders of pioneering ATMP (Advanced Therapy Medicinal Products) companies and their most senior executives responsible for the latest technologies and strategies driving the industry forward. The Congress brings together a massive community of 3,300 global executives at ExCeL London over two incredible days to be inspired by 300 speakers and 75 innovative start-ups.

This influential gathering features speakers representing the entire value chain of cell and gene therapy development, ensuring a comprehensive and collaborative program. Attendees include forward-thinking executives from pharma, biotech, and startup companies, alongside key stakeholders such as researchers, clinicians, academics, Health Technology Assessment (HTA) bodies, payers, and regulators. The event serves as the definitive platform for connecting, sharing scientific advancements, and developing the strategic vision necessary to push advanced therapies from development into patient care.